Disease control should be the goal of therapy for WM patients
Blood Adv
.
2017 Nov 28;1(25):2483-2485.
doi: 10.1182/bloodadvances.2017005645.
Authors
Efstathios Kastritis
1
,
Meletios A Dimopoulos
1
Affiliation
1
Department of Clinical Therapeutics, School of Medicine, National and Kapodistrian University of Athens, Athens, Greece.
PMID:
29296898
PMCID:
PMC5729615
DOI:
10.1182/bloodadvances.2017005645
Abstract
Publisher's Note:
This article has a companion
.